9F1L
First bromodomain of BRD4 in complex with ISOX-DUAL based degrader 35
This is a non-PDB format compatible entry.
Summary for 9F1L
Entry DOI | 10.2210/pdb9f1l/pdb |
Descriptor | Bromodomain-containing protein 4, 1,2-ETHANEDIOL, N-[2-[2-[(3R)-2,6-bis(oxidanylidene)piperidin-3-yl]-1,3-bis(oxidanylidene)isoindol-4-yl]oxyethyl]-2-[4-[2-[2-[2-[4-[3-(dimethylamino)propoxy]phenyl]ethyl]-5-(3,5-dimethyl-1,2-oxazol-4-yl)benzimidazol-1-yl]ethyl]piperazin-1-yl]ethanamide, ... (4 entities in total) |
Functional Keywords | bromodomain, epigenetic drugs, inhibitor, protacs, thalidomide, gene regulation |
Biological source | Homo sapiens (human) |
Total number of polymer chains | 1 |
Total formula weight | 16235.67 |
Authors | Balourdas, D.I.,Edmonds, A.K.,Marsh, G.P.,Maple, H.J.,Spencer, J.,Knapp, S.,Joerger, A.C.,Structural Genomics Consortium (SGC) (deposition date: 2024-04-19, release date: 2024-09-11) |
Primary citation | Balourdas, D.I.,Edmonds, A.K.,Marsh, G.P.,Maple, H.J.,Spencer, J.,Knapp, S.,Joerger, A.C.,Structural Genomics Consortium (SGC) First bromodomain of BRD4 in complex with ISOX-DUAL based degrader 35 to be published, |
Experimental method | X-RAY DIFFRACTION (1.30000625447 Å) |
Structure validation
Download full validation report